Novanta Inc. (NOVT) Stock Analysis
Range Bound setup
Technology · Scientific & Technical Instruments
Hold if already holding. Not a fresh buy at $159.46, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Negative momentum.
Novanta Inc. is a global supplier of precision technology components for medical and advanced industrial OEMs across two segments: Automation Enabling Technologies ($500.8M revenue, laser beam steering, motion control, robotics) and Medical Solutions ($479.8M revenue,... Read more
Hold if already holding. Not a fresh buy at $159.46, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Negative momentum. Chart setup: RSI 46 mid-range, Bollinger mid-band. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.2/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 50d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-15Recent Developments — Novanta Inc.
Latest news
- NEWS Why Novanta Shares Are Suddenly Sliding Today - TipRanks — TipRanks negative
- NEWS Insider Selling: Novanta (NASDAQ:NOVT) CEO Sells 6,500 Shares of Stock - MarketBeat — MarketBeat negative
- NEWS Novanta (NOVT) CEO sells 6,500 shares under pre-set 10b5-1 trading plan - Stock Titan — Stock Titan negative
- NEWS Novanta (NOVT) CEO sells 6,500 shares in pre-set 10b5-1 trades - Stock Titan — Stock Titan negative
- NEWS Novanta Corporation Closing Their Mukilteo Location - My Everett News — My Everett News negative
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomertop-2 OEM medical customers10-K Item 1: 'two OEM customers, each operating primarily in the medical end market across multiple product lines, represented approximately 12% and 11%, respectively, of our consolidated revenue.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $159.46, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Negative momentum. Chart setup: RSI 46 mid-range, Bollinger mid-band. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $168.41 (+5.6%), stop $148.27 (−7.5%), A.R:R -0.6:1. Score 5.2/10, moderate confidence.
Take-profit target: $168.41 (+5.6% upside). Target $168.41 (+5.6%), stop $148.27 (−7.5%), A.R:R -0.6:1. Stop-loss: $148.27.
Analyst target reached - limited upside remaining; Negative momentum; Elevated risk factors.
Novanta Inc. trades at a P/E of 114.7 (forward 38.7). TrendMatrix value score: 4.7/10. Verdict: Hold.
9 analysts cover NOVT with a consensus score of 4.3/5. Average price target: $175.
What does Novanta Inc. do?Novanta Inc. is a global supplier of precision technology components for medical and advanced industrial OEMs across...
Novanta Inc. is a global supplier of precision technology components for medical and advanced industrial OEMs across two segments: Automation Enabling Technologies ($500.8M revenue, laser beam steering, motion control, robotics) and Medical Solutions ($479.8M revenue, insufflators, imaging, RFID, light engines). Revenue is earned from approximately 3,000 employees in 15+ countries selling proprietary components embedded in OEM customers' long-lifecycle systems. In 2025, two OEM medical customers represented approximately 12% and 11% of consolidated revenue, respectively.